EUVIMEDOpdag EUVIMED
Kohortenstudie

Temporal trends of de novo urological malignancy in renal transplant recipients without a cancer history: A longitudinal cohort study

Kevin Lu iD, Kun-Yuan Chiu

Clinical Transplantation · 2023

DOI: 10.1111/ctr.15047 ↗

At a glance

Kohortenstudie in Clinical Transplantation, 2023. Written by Kevin Lu and 1 co-authors. Institution: Department of Urology, Taichung Veterans General Hospital, Taichung, Taiwan. Major MEDLINE topics: Kidney Transplantation, Neoplasms, Urologic Neoplasms. Cited 2 times so far (Crossref); 26 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

The incidence of malignancies after successful kidney transplantation has historically been higher than in the general population, with adverse impact on clinical outcomes. However, uncertainty remains as to which cancers occur at what time points after kidney transplantation.

Methods

We conducted a longitudinal cohort study to investigate the temporal trends and topographic patterns of de novo malignancies to optimize surveillance protocols and improve transplant outcome in renal transplant recipients. Measurement of death and cancer events was performed to calculate the cumulative risk of events of interest.

Results

Between 2000 and 2013, 3169 renal transplant recipients were retrospectively screened; 3035 (96%) of them met eligibility criteria and were evaluated with a follow‐up of 27612 person‐years. There was suboptimal overall survival and malignancy‐free survival in renal transplant recipients compared to reference groups (HR: 1.65; 95% CI: 1.50–1.82; p < .001; HR: 2.33; 95% CI: 2.04–2.66; p < .001, respectively). Among renal transplant recipients, urological malignancies were predominant (57.5%), followed by digestive tract malignancies (21.4%). The cancer risks of the urinary bladder and upper urinary tract were lower in male subjects (HR: .48; 95% CI: .33–.72; p < .001; HR: .34; 95% CI: .20–.59; p < .001, respectively). The temporal trends of urological malignancies among renal transplant recipients were expressed in a bimodal pattern, with M‐shaped peaks at 3 and 9 years, with gender disparity.

Conclusions

In renal transplant recipients, cancer occurrences are shown as M‐shaped twin peaks. Our study highlights that specific customized 'targeted' strategies for cancer surveillance programs are required to optimize posttransplant care.

Subjects

MeSH terms (MEDLINE)

Kidney TransplantationNeoplasmsUrologic NeoplasmsHumansMaleLongitudinal StudiesRetrospective StudiesCohort StudiesIncidenceTransplant RecipientsRisk Factors

Author keywords

cancer surveillanceend-stage renal diseasemalignancyrenal transplantationurological malignancy

Authors and institutions

  • Department of Urology, Taichung Veterans General Hospital, Taichung, Taiwan.
  • School of Medicine, National Yang-Ming Chiao Tung University, Taipei, Taiwan.
  • Department of Applied Chemistry, National Chi Nan University, Puli, Nantou, Taiwan.

ORCID profiles: Kevin Lu

Cite

APA

Lu, K., & Chiu, K. Y. (2023). Temporal trends of de novo urological malignancy in renal transplant recipients without a cancer history: A longitudinal cohort study. Clinical Transplantation. https://doi.org/10.1111/ctr.15047

Vancouver

Lu K, Chiu KY. Temporal trends of de novo urological malignancy in renal transplant recipients without a cancer history: A longitudinal cohort study. Clinical Transplantation. 2023. doi:10.1111/ctr.15047

BibTeX
@article{Lu2023,
  author = {Lu, Kevin and Chiu, Kun-Yuan},
  title = {Temporal trends of de novo urological malignancy in renal transplant recipients without a cancer history: A longitudinal cohort study},
  journal = {Clinical Transplantation},
  year = {2023},
  doi = {10.1111/ctr.15047}
}
Start for free →